1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
649D236CB302E086B85257DA200704510
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-optimizing-the-managed-markets-function-compensation-and-efficiency?opendocument
18
19opendocument
2018.206.48.142
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Managed Care Resource Benchmarks

Optimizing the Managed Markets Function: Compensation, Clinical Specialists and Staffing Levels

ID: 5338


Features:

14 Info Graphics

11 Data Graphics

70+ Metrics


Pages/Slides: 30


Published: 2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Optimizing the Managed Markets Function: Compensation, Clinical Specialists and Staffing Levels"


STUDY OVERVIEW

Commercial and government payers continue to extend their influence on the pharmaceutical sector. Consequently, the managed markets function also has grown in importance, with pharmaceutical organizations seeking innovative ways to optimize the role of managed markets.

Best Practices, LLC undertook this study to benchmark the compensation structure, the role of clinical specialists and staffing levels for managed markets functions within small and mid-sized pharmaceutical companies. Leading metrics in the study include the bonus structure of area directors and account managers, the role and activities of clinical specialists, and the average revenue supported per FTE in managed markets. The study will enable managed markets leaders to optimize the compensation structure and specialist staffing within their function.


KEY TOPICS

  • Compensation
  • The Clinical Specialist Role
  • Staffing Levels
SAMPLE KEY METRICS
  • Bonus structure for area directors and account managers
  • Percentage of bonus structure tied to MBO and sales plan
  • Additional perks for high-performers exceeding the bonus cap
  • Clinical specialists supporting managed markets
  • Reporting relationships for clinical specialists
  • Average revenue supported per FTE in managed markets
  • Average FTE allocation for various managed markets sub functions

SAMPLE KEY FINDING
  • All participants noted that bonus targets for area directors and account managers focused on a combination of Management by Objectives (MBO) and sales plan attainment. The weighting of MBO vs. Sales Plan Attainment for account managers was approximately 50/50. For area directors, the weighting shifted closer to an average of 60/40 in favor of MBO.

METHODOLOGY

Best Practices, LLC engaged 11 commercial leaders from targeted small and mid-sized companies that align well with one another in terms of size, market position and resource levels. These 11 companies completed online surveys and selected participants also were engaged in interviews.

Industries Profiled:
Biotech; Pharmaceutical; Health Care


Companies Profiled:
United Therapeutics; Horizon Pharma; actavis; Purdue Pharma; Actelion; Daiichi Sankyo; Galderma; Upsher-Smith; Jazz Pharmaceuticals; Eisai; Shire

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.